These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35838025)

  • 1. The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.
    Peng W; Li W; Zhang X; Cen W; Liu Y
    J Clin Lab Anal; 2022 Sep; 36(9):e24609. PubMed ID: 35838025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
    Wang N; Chen Y; Wu J
    Oncol Lett; 2023 May; 25(5):201. PubMed ID: 37113398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
    Zhuang L; Yang Z; Meng Z
    Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
    He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma.
    Zhang T; Shi W; Tian K; Kong Y
    World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti-tumor effects.
    Poyil PK; Siraj AK; Padmaja D; Parvathareddy SK; Thangavel S; Alobaisi K; Diaz R; Begum R; Haqawi W; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Mol Oncol; 2024 Mar; 18(3):691-706. PubMed ID: 38361222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.
    Cai Y; Wu D; Zhan L
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101796. PubMed ID: 34500119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher circular RNA_0015278 correlates with absence of extrathyroidal invasion, lower pathological tumor stages, and prolonged disease-free survival in papillary thyroid carcinoma patients.
    Ding H; Wang X; Liu H; Na L
    J Clin Lab Anal; 2021 Jul; 35(7):e23819. PubMed ID: 33969549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-kinase interacting protein 1 as a potential biomarker of advanced tumor features and increased recurrence risk in papillary thyroid carcinoma patients.
    Zhang L; Tao H; Ke K; Ma C
    J Clin Lab Anal; 2020 Oct; 34(10):e23452. PubMed ID: 32643206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
    Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
    BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis.
    Peng S; Yu J; Wang Y
    Ir J Med Sci; 2024 Feb; 193(1):85-93. PubMed ID: 37523068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
    Zhou SL; Tang QL; Zhou SX; Ren RZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Katanin P60 and P80 in papillary thyroid carcinoma patients: Indicators for exacerbated tumor features and worse disease-free survival.
    Chen Q; Lin F; Lin E; Huang Q; Wu G
    J Clin Lab Anal; 2020 Dec; 34(12):e23502. PubMed ID: 33274499
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Rong MH; Li JD; Zhong LY; Huang YZ; Chen J; Xie LY; Qin RX; He XL; Zhu ZH; Huang SN; Zhou XG
    Exp Biol Med (Maywood); 2022 Mar; 247(5):395-408. PubMed ID: 34743578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis.
    Wang C; Xie X; Li W; Jiang D
    J Clin Lab Anal; 2022 Sep; 36(9):e24647. PubMed ID: 35949045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers.
    Fang L; Liu Q; Cui H; Zheng Y; Wu C
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
    Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
    J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
    Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
    J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
    Ding Y; Yu S; Bao Z; Liu Y; Liang T
    J Neurooncol; 2017 May; 133(1):87-95. PubMed ID: 28432586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLK4 reflects extrathyroidal invasion, high tumor stage and poor prognosis in papillary thyroid carcinoma patients.
    Hu X; Yu J; Chen M; Pang R
    Biomark Med; 2024 Mar; 18(5):169-179. PubMed ID: 38440866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.